Categories AlphaGraphs, Earnings, Health Care

Vertex Pharmaceuticals reports 14% growth in Q1 revenue: Infographic

Vertex Pharmaceuticals (NASDAQ: VRTX) reported first-quarter 2021 financial results after the regular market hours on Thursday. The pharmaceutical firm reported Q1 revenue of $1.72 billion, up 14% year-over-year and above the Wall Street projection. Net income of $2.98 per share was also above the target that analysts had anticipated.

VRTX shares were down 0.4% immediately following the announcement. The stock has fallen 7% since the beginning of this year.

Vertex Pharma Q1 2021 earnings

Looking forward to listening to management / analyst comments on the results? Stay tuned here for Vertex Pharmaceuticals Q1 earnings call transcript

Prior performance

Most Popular

CCL Earnings: Highlights of Carnival Corporation’s Q4 2025 results

Cruise operator Carnival Corporation & plc (NYSE: CCL) on Friday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. Earnings topped analysts' expectations. Revenues

Lamb Weston (LW) Q2 2026 Earnings: Key financials and quarterly highlights

Lamb Weston Holdings, Inc. (NYSE: LW) reported its second quarter 2026 earnings results today. Net sales inched up 1% year-over-year to $1.62 billion. Net sales at constant currency remained flat.

Paychex reports higher Q2 FY26 revenue and earnings; EPS beats estimates

Paychex Inc. (NASDAQ: PAYX) on Friday reported stronger-than-expected adjusted earnings for the second quarter of fiscal 2026. Revenues grew 18% year-over-year. The Rochester-based human capital management solutions provider reported revenues

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top